# OnCo record paper-apt-tolaney-nejm-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-apt-tolaney-nejm-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-apt-tolaney-nejm-2015" ;
  schema:name "APT: adjuvant paclitaxel and trastuzumab for small, node-negative HER2-positive breast cancer"@en ;
  schema:description "Twelve weeks of paclitaxel with a year of trastuzumab, and no anthracycline, was enough to keep more than 98 percent of women with small node-negative HER2-positive breast cancers free of recurrence at three years."@en ;
  schema:url <https://onco.cc/key-papers/paper-apt-tolaney-nejm-2015/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1406281>, <https://pubmed.ncbi.nlm.nih.gov/25564897/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1406281> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Tolaney SM, Barry WT, Dang CT, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-positive-early-breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .